Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2016 Mar;55(2):199-203.

Comparison of 2-Ethyl-Cyanoacrylate and 2-Butyl-Cyanoacrylate for Use on the Calvaria of CD1 Mice

Affiliations
Comparative Study

Comparison of 2-Ethyl-Cyanoacrylate and 2-Butyl-Cyanoacrylate for Use on the Calvaria of CD1 Mice

Joanne J Sohn et al. J Am Assoc Lab Anim Sci. 2016 Mar.

Abstract

Short-chain cyanoacrylates (SCCA), such as ethyl-2-cyanoacrylate (KrazyGlue, Aron Alpha, Columbus, OH) are commonly used as commercial fast-acting glues. Although once used in clinical medicine as skin adhesives, these products caused tissue toxicity and thus their use in live tissue was discontinued. SCCA were replaced by longer-chain versions (LCCA), such as butyl-cyanoacrylate (Vetbond, 3M, St Paul, Minnesota), which were found to be less toxic than the short-chain formulations. Some researchers prefer to use SCCA due to the belief that they create a stronger bond than do the longer-chain counterparts. In survival surgeries, we compared the bone thickness, bone necrosis, fibrosis, inflammation, and bone regeneration in the calvaria of control (naïve), surgery-only, SCCA-treated, and LCCA-treated mice (n = 20 per group). At 1 and 14 d after surgery, all mice except those treated with SCCA showed statistically similar bone measurements to those of the naive control group. The SCCA group had significantly less bone regeneration than did all other groups. These results suggest that the application of SCCA causes bone damage resulting in the loss of bone regeneration. This finding may assist investigators in choosing a tissue glue for their studies and may support the IACUC in advocating the use of pharmaceutical-grade tissue glues.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Trade names for different types of cyanoacrylates.
Figure 2.
Figure 2.
Histologic scoring scale.
Figure 3.
Figure 3.
Change in bone density between days 1 and 14. C, control (naïve) mice; S, surgery-only mice; LCCA, mice treated with long-chain cyanoacrylate tissue glue; SCCA, mice treated with short-chain cyanoacrylate product.

Similar articles

Cited by

References

    1. Agterberg MJ, Spoelstra EN, van der Wijst S, Brakkee JH, Wiegant VM, Hamelink R, Brouns K, Westerink BH, Remie R. 2010. Evaluation of temperature rise and bonding strength in cements used for permanent head attachments in rats and mice. Lab Anim 44:264–270. - PubMed
    1. Animal Welfare Act as Amended. 2008. 7 USC §2131–2159.
    1. Cascarini L, Kumar A. 2007. Case of the month. Honey I glued the kids—tissue adhesives are not the same as “superglue”. Emerg Med J 24:228–229. - PMC - PubMed
    1. Chou SN. 1977. Use of cyanoacrylate. J Neurosurg 46:266. - PubMed
    1. Clarke TF. 2011. Cyanoacrylate glue burn in a child—lessons to be learned. J Plast Reconstr Aesthet Surg 64:e170–e173. - PubMed

Publication types